USANA Health Sciences Inc... (USNA)
NYSE: USNA
· Real-Time Price · USD
30.55
-0.74 (-2.36%)
At close: Aug 14, 2025, 3:59 PM
30.20
-1.15%
After-hours: Aug 14, 2025, 06:00 PM EDT
USANA Health Sciences Income Statement
Financials in USD. Fiscal
year is
February - January.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
Revenue | 899.22M | 876.24M | 854.5M | 861.97M | 875.12M | 900.45M | 921.01M | 927.89M | 947.82M | 974.09M | 998.6M | 1.04B | 1.08B | 1.15B | 1.19B | 1.23B | 1.25B | 1.18B |
Cost of Revenue | 180.44M | 170.59M | 161.21M | 164.98M | 168.25M | 171.24M | 176.69M | 180.8M | 184.84M | 191.03M | 193.89M | 199.98M | 204.13M | 211.63M | 217.9M | 224.4M | 230.04M | 220.7M |
Gross Profit | 718.78M | 705.65M | 693.29M | 697M | 706.87M | 729.21M | 744.32M | 747.08M | 762.99M | 783.07M | 804.71M | 837.96M | 874.86M | 939.73M | 968.57M | 1.01B | 1.02B | 955.3M |
Operating Income | 56.2M | 57.32M | 66.32M | 82.33M | 84.34M | 90.9M | 93.07M | 86.15M | 85.75M | 90.72M | 97.19M | 111.39M | 134.96M | 159.31M | 170.19M | 191.22M | 195.81M | 181.68M |
Interest Income | 7.22M | 9.37M | 11.32M | 11.49M | 11.08M | 10.54M | 9.64M | 8.19M | 6.38M | 4.83M | 3.79M | 2.92M | 2.49M | 2.49M | 2.52M | 2.58M | 2.56M | 2.31M |
Pretax Income | 64.59M | 65.98M | 76.35M | 92.53M | 94.46M | 101.06M | 102.45M | 98.64M | 101.34M | 103.83M | 108.62M | 117.47M | 134.59M | 159.59M | 170.64M | 193.53M | 197.45M | 183.12M |
Net Income | 34.15M | 34.92M | 42.06M | 54.34M | 55.08M | 61.94M | 63.79M | 59.82M | 63.4M | 65.26M | 69.35M | 76.88M | 89.28M | 108.35M | 116.5M | 135.81M | 138.99M | 128.73M |
Selling & General & Admin | 395.03M | 376.96M | 445.58M | 526.78M | 618.72M | 638.31M | 651.25M | 655.68M | 666.56M | 681.68M | 697.1M | 721.39M | 740.15M | 780.66M | 798.37M | 814.06M | 827.99M | 773.62M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.56M | 11.56M | 11.56M | 11.56M | 11.11M | 11.11M | 11.11M | 11.11M | 10.63M | 10.63M | 10.63M |
Other Expenses | 267.56M | 267.21M | 177.03M | 83.53M | -535K | -186K | 1.66M | 1.91M | 2.5M | 2.44M | 1.01M | 897K | -117K | 531K | 450K | 2.3M | 1.64M | 1.45M |
Operating Expenses | 662.58M | 644.52M | 623.15M | 610.85M | 618.72M | 638.31M | 651.25M | 655.68M | 666.56M | 681.68M | 697.1M | 721.39M | 740.15M | 780.66M | 798.37M | 814.06M | 827.99M | 773.62M |
Interest Expense | 848K | 640K | 281K | 297K | 291K | 283K | 262K | 149K | 138K | 191K | 192K | 178K | 164K | 84K | 57K | 39K | 1.4M | 1.6M |
Selling & Marketing Expenses | n/a | 90.37M | 186.13M | 282.01M | 371.94M | 383.94M | 394.26M | 396.25M | 404.42M | 421.24M | 434.79M | 451.6M | 469.73M | 504.39M | 519.27M | 534.37M | 549.29M | 506.28M |
Cost & Expenses | 790.58M | 766.48M | 788.18M | 779.64M | 790.78M | 809.55M | 827.94M | 836.48M | 851.4M | 872.7M | 890.99M | 921.37M | 944.28M | 992.29M | 1.02B | 1.04B | 1.06B | 994.33M |
Income Tax Expense | 29.77M | 31.17M | 34.29M | 38.19M | 39.37M | 39.12M | 38.66M | 38.83M | 37.94M | 38.57M | 39.27M | 40.59M | 45.31M | 51.24M | 54.14M | 57.71M | 58.46M | 54.39M |
Shares Outstanding (Basic) | 18.51M | 19.05M | 19.06M | 19.08M | 19.07M | 19.17M | 19.13M | 19.25M | 19.3M | 19.28M | 19.21M | 19.22M | 19.21M | 19.35M | 19.39M | 19.96M | 20.25M | 20.89M |
Shares Outstanding (Diluted) | 18.54M | 19.09M | 19.1M | 19.08M | 19.16M | 19.3M | 19.25M | 19.37M | 19.43M | 19.33M | 19.26M | 19.25M | 19.24M | 19.48M | 19.67M | 20.16M | 20.45M | 21.1M |
EPS (Basic) | 1.81 | 1.84 | 2.21 | 2.85 | 2.88 | 3.23 | 3.32 | 3.11 | 3.30 | 3.40 | 3.61 | 3.98 | 4.57 | 5.46 | 5.77 | 6.61 | 6.69 | 6.13 |
EPS (Diluted) | 1.80 | 1.82 | 2.19 | 2.83 | 2.86 | 3.21 | 3.30 | 3.09 | 3.28 | 3.39 | 3.59 | 3.96 | 4.54 | 5.41 | 5.71 | 6.55 | 6.63 | 6.08 |
EBITDA | 96.73M | 91.59M | 96.45M | 111.63M | 113.15M | 121.6M | 123.11M | 119.57M | 122.52M | 125.05M | 130.22M | 139.46M | 156.63M | 181.99M | 192.89M | 215.62M | 221.01M | 206.97M |
EBIT | 65.44M | 64.2M | 74.22M | 90.42M | 92.33M | 101.35M | 101.03M | 96.82M | 98.88M | 101.39M | 107.61M | 116.57M | 134.71M | 159.06M | 170.19M | 191.22M | 195.81M | 181.68M |
Depreciation & Amortization | 31.29M | 27.39M | 22.23M | 21.22M | 20.82M | 20.25M | 20.39M | 20.78M | 21.04M | 21.03M | 21.41M | 21.82M | 21.88M | 22.31M | 22.19M | 22.05M | 22.16M | 22.25M |